A complete application in a minute
Tailored resume and cover letter, ready to send.
Orion Corporation seeks a Head of US Market Access to build and lead the US Market Access function, shaping payer strategy, pricing, contracting, and patient access for upcoming oncology launches.
You will define the operating model, recruit and develop a high-performing team, and collaborate with global leadership to align with enterprise strategy. This is a hybrid role based in Boston, MA.
Orion is entering an exciting phase of growth in oncology and is seeking an accomplished, entrepreneurial Head of US Market Access to build and lead our US Market Access organization.
This unique opportunity will allow you to establish our US market access capability from the ground up and play a central role in preparing for the launch of innovative oncology medicines.
As a strategic leader, you will define and execute market access strategies that enable patients to benefit from Orion's therapies while supporting sustainable, long-term business success.
Working closely both with lean, evolving US team and global leadership, you will lead efforts across payer strategy, pricing, reimbursement, contracting, trade and distribution, specialty pharmacy, patient services, and evidence-based access planning.
The position will report to VP Market Access & Information Services, Innovative Medicines.
At Orion, we are committed to bringing innovative therapies to patients with significant unmet medical needs. This role offers a rare opportunity to influence both strategy and execution at a pivotal moment in our oncology growth journey.
You will have the chance to:
Please visit our website to find further information about our values and Orion as an employer https://www.orion.fi/en/careers/orion-as-an-employer/.
The Innovative Medicines business division is responsible for the strategic leadership of Orion’s business in core therapy areas, Pain and Oncology, covering all activities from pipeline and portfolio building to commercialization. Innovative Medicines Business Division, where patients’ unmet needs meet innovation, bringing new treatments to promote health and well-being in society.
Orion’s pharmaceutical innovations are created within its R&D organization. We employ top professionals in the field of drug discovery and development. We work globally: in Espoo and Turku in Finland, in Cambridge and Nottingham in England and in Cambridge, USA. Orion R&D and the Innovative Medicines business division are dedicated to becoming a global player in oncology and pain therapy areas.
Orion Pharma is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years.
We’re home to more than 4,000 Orionees around the world, and we’re proud to be known as a responsible employer and a great place to work. At Orion Pharma, people are truly valued and trusted, encouraged to grow, and supported by a culture where every voice is heard. We appreciate each other, strive for excellence, and build the future.
Together we develop, manufacture, and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Our extensive portfolio includes proprietary and generic medicines as well as consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion Pharma are used to treat cancer, neurological diseases, respiratory diseases, and more.
We offer careers with a clear purpose: empowering people to live their lives to the fullest.